NCT06384859
Not yet recruiting
Phase 4
Effectiveness of Extracorporeal Shockwave Therapy Combined With Platelet-rich Plasma in the Treatment of Chronic Insertional Achilles Tendinopathy
ConditionsInsertional Achilles Tendinopathy
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Insertional Achilles Tendinopathy
- Sponsor
- Mahidol University
- Enrollment
- 94
- Locations
- 1
- Primary Endpoint
- VAS
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
The goal of this clinical trial is to learn about the effectiveness of extracorporeal shockwave(ESWT) combined with platelet-rich plasma(PRP) to treat chronic insertional tendinopathy. The main questions it aims to answer are:
Does ESWT combined with PRP treatment reduce the symptom and improve functional score after treatment? What medical complication do participants have when receive the treatment?
Researchers will compare ESWT combined with PRP to ESWT treatment alone to see if ESWT combined with PRP works to treat chronic insertional tendinopathy.
Participants will:
- Receive ESWT once a week for 4 weeks then receive PRP injection at a week later or ESWT once a week for 4 weeks
- Visit the clinic at 6 weeks, 3 months, 6 months and 1 year after treatment for checkups and record functional score
Investigators
Eligibility Criteria
Inclusion Criteria
- •Diagnosed with insertional Achilles tendinopathy
- •Had symptom more than 6 months
- •Failed other standard conservative treatment (rest, medication, activity modification, stretching exercise, and heel lift orthosis)
Exclusion Criteria
- •Receive corticosteroid injection at the Achilles insertion
- •History of infection around ankle and heel
- •Has neurological deficit
- •Has a contraindication for ESWT(hemophilia, coagulopathy or foot and ankle malignancy)
Outcomes
Primary Outcomes
VAS
Time Frame: 6 week, 3 months, 6 months and 1 year after treatment
Visual Analogue Scale
Secondary Outcomes
- VAS-FA(6 week, 3 months, 6 months and 1 year after treatment)
- FFI(6 week, 3 months, 6 months and 1 year after treatment)
- FAAM(6 week, 3 months, 6 months and 1 year after treatment)
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Not Applicable
Efficacy of the Extracorporeal Shock Wave Therapy in Athletes With Patellar TendinopathyPatellar TendinopathyPatellar Tendon PainNCT06705881Ahi Evran University Education and Research Hospital32
Completed
Not Applicable
Can Extracorporeal Shock Wave Therapy Be Effective in Temporomandibular Joint DiseaseTemporomandibular Joint Disc Displacement, With ReductionExtracorporeal Shock Wave TherapyNCT05599113Yuzuncu Yıl University80
Unknown
Phase 3
Treatment of Refractory Angina Pectoris by Shock Wave TherapyAngina PectorisNCT00776568Universal Research Group60
Recruiting
Not Applicable
Effects of Focal Extracorporeal Shock Wave Therapy in the Treatment of Temporomandibular Disorders of Muscular OriginTemporomandibular Joint DisordersExtracorporeal Shockwave TherapyNCT05907239University of Sao Paulo General Hospital100
Completed
Not Applicable
Chronic Pelvic Pain Syndrome in MalesPelvic Pain SyndromeNCT06369545Biruni University38